Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 67739

2 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
March 13, 2014
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Blu Pharmaceuticals Inc

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

2 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 2

Metformin Hydrochloride Tablets USP 500 mg, 500 tablets Rx Only, Manufactured by Blu Caribe Dorado PR 00646. Distributed by Blu Pharmaceuticals Franklin NY 42134 NDC 24658-290-05

D-1301-2014
Recall number
D-1301-2014
Initiated
March 13, 2014
Classification
Class II
Status
Terminated
Recalling firm
Blu Pharmaceuticals Inc
Quantity
14,000 tablets

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Defective container: Product distributed without inner seal on bottles.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Defective container: Product distributed without inner seal on bottles.

Code information

Lot # 13E0008F3P8V; Exp. 03/15

Distribution pattern

NJ, UT, IL and CT

drug · product 2 of 2

Metformin Hydrochloride Tablets USP 1000 mg, 500 tablets Rx Only, Manufactured by Blu Caribe Dorado PR 00646. Distributed by Blu Pharmaceuticals Franklin NY 42134, NDC 24658-0292-05

D-1302-2014
Recall number
D-1302-2014
Initiated
March 13, 2014
Classification
Class II
Status
Terminated
Recalling firm
Blu Pharmaceuticals Inc
Quantity
101,500 tablets

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Defective container: Product distributed without inner seal on bottles.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Defective container: Product distributed without inner seal on bottles.

Code information

Lot # 13E0014F1P8V; Exp. 04/15

Distribution pattern

NJ, UT, IL and CT